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adhesion through TSC1-binding domain and the
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T

uberous sclerosis complex (TSC) 1 and TSC2 are
thought to be involved in protein translational regulation and cell growth, and loss of their function is
a cause of TSC and lymphangioleiomyomatosis (LAM).
However, TSC1 also activates Rho and regulates cell adhesion. We found that TSC2 modulates actin dynamics and
cell adhesion and the TSC1-binding domain (TSC2-HBD)
is essential for this function of TSC2. Expression of TSC2
or TSC2-HBD in TSC2/ cells promoted Rac1 activation, inhibition of Rho, stress fiber disassembly, and focal

adhesion remodeling. The down-regulation of TSC1 with
TSC1 siRNA in TSC2/ cells activated Rac1 and induced loss of stress fibers. Our data indicate that TSC1
inhibits Rac1 and TSC2 blocks this activity of TSC1. Because TSC1 and TSC2 regulate Rho and Rac1, whose
activities are interconnected in a reciprocal fashion, loss
of either TSC1 or TSC2 function may result in the deregulation of cell motility and adhesion, which are associated
with the pathobiology of TSC and LAM.

Introduction
Tumor suppressors tuberous sclerosis complex (TSC) 1 and
TSC2, also named as hamartin and tuberin, respectively, play a
critical role in protein translational regulation and cell growth
from Drosophila melanogaster to mammals (Krymskaya,
2003; Kwiatkowski, 2003; Manning and Cantley, 2003). TSC1
and TSC2 proteins form a cytosolic heterodimer and exert their
function as negative regulators of the mammalian target of
rapamycin (mTOR) signaling pathway (Nellist et al., 1999;
Goncharova et al., 2002; Kwiatkowski et al., 2002). TSC2
encodes in its COOH terminus a GTPase-activating protein
(GAP) for small GTPase Rheb (Ras homologue enriched in
brain), whose activity antagonizes mTOR signaling (Gao et al.,
2002; Garami et al., 2003; Inoki et al., 2003a; Li et al., 2004).
Growth factors, insulin, nutrients, and the cellular energy levels
regulate the activity of TSC2 (McManus and Alessi, 2002;
Inoki et al., 2003b).
TSC1 (gene encoding protein TSC1, hamartin) and TSC2
(gene encoding protein TSC2, tuberin) genes are susceptibility
The online version of this article includes supplemental material.
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factors for TSC (Crino and Henske, 1999; Sparagana and Roach,
2000; Cheadle et al., 2000) and lymphangioleiomyomatosis
(LAM; Sullivan, 1998; Carsillo et al., 2000; Johnson and Tattersfield, 2002). The pathobiology of TSC and LAM are generally
thought to be linked to abnormal cell growth. However, the
neurological manifestations of TSC have been defined as a
“neuronal migration disorder” and occur due to aberrant neuronal
motility during brain development (Crino and Henske, 1999;
Vinters et al., 1999; Gutmann et al., 2000; Sparagana and
Roach, 2000); and LAM is a potentially metastatic disease (Yu
et al., 2001; Henske, 2003; Karbowniczek et al., 2003), suggesting
a role for TSC1 and TSC2 in cell motility. Furthermore, TSC1deficient murine embryonic fibroblasts have an impaired ability
to form serum-induced stress fibers and focal adhesions (Kwiatkowski et al., 2002). Conversely, overexpression of TSC1 or
TSC2 in human kidney epithelial cells results in increased
E-cadherin expression, increased cell adhesion, and reduced
chemotactic migration (Astrinidis et al., 2002; Li et al., 2003).
Importantly, TSC1 binds to the ezrin-radixin-moesin (ERM)
family of actin-binding proteins (Lamb et al., 2000). In cultured
cortical neurons, TSC1 physically anchors intermediate filaments to the actin cytoskeleton by binding to both neurofilament light chains and the ERM proteins (Haddad et al., 2002).
Together, these data suggest the potential involvement of TSC2
and TSC1 in cell motility. However, the precise mechanism and
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the relevance of these findings to aberrant neuronal motility in
TSC and LAM metastasis remains an enigma.
The Rho family of small GTPases, RhoA, Rac, and Cdc42,
are key regulators of actin cytoskeletal remodeling, cell adhesion, and migration. RhoA promotes the formation of stress fibers that are linked to focal adhesions; Rac induces the formation
of membrane ruffles and lamellipodia; and Cdc42 induces
filopodia formation (Etienne-Manneville and Hall, 2002; Burridge and Wennerberg, 2004). Reciprocal activation of RhoA,
Rac, and Cdc42 is critical for the regulation of cell adhesion and
motility (Horwitz and Parsons, 1999; Etienne-Manneville and
Hall, 2002), and dysregulation of this balance promotes cell
transformation and metastasis (Sahai and Marshall, 2002). Recent studies suggest that TSC1 regulates Rho activity through the
Rho-activating domain within its NH2 terminus by an unknown
mechanism (Lamb et al., 2000). Interestingly, the Rho-activating
domain of TSC1 (amino acids 145–510) overlaps with the domain that binds TSC2: the amino acids 302–430 of TSC1
(Hodges et al., 2001) associate with amino acids 1–418 of TSC2
and are required for TSC1–TSC2 complex formation, which potentially stabilizes each protein (Nellist et al., 1999; Henske,
2003; Krymskaya and Shipley, 2003). These data suggest that

the interaction of TSC1 with TSC2 may be important for TSC1dependent Rho activation and cell adhesion. However, how
TSC2 and TSC1 complex formation is involved in regulating actin remodeling and adhesion has not been identified.
Here, we show that TSC2 regulates the actin cytoskeleton
and focal adhesion, and the TSC1-binding domain of TSC2
(TSC2-HBD), which corresponds to amino acids 1–460 in the
NH2 terminus of TSC2, is both necessary and sufficient for this
function. Importantly, down-regulation of TSC1 with siRNA in
TSC2/ cells also induces disassembly of stress fibers and
focal adhesion remodeling, indicating that TSC1 is required for
TSC2-dependent actin remodeling. Furthermore, we show that
the role of TSC2 in modulating actin dynamics is distinct from
its function as a negative regulator of the rapamycin-sensitive
mTOR/p70 S6 kinase (S6K) signaling pathway.

Results
TSC2 is necessary for dynamic membrane
protrusions during wound closure

To explore whether or not TSC2 regulates cell motility, we performed live imaging of the wound closure of TSC2-deficient

Figure 1. Re-expression of TSC2 changes TSC2/ cell morphology and dynamics during wound closure. (A) Phase-contrast micrograph of time-lapse
analysis of TSC2/ cell motility during wound closure at 4 h after wound scraping; images are representative of three independent experiments.
(B) Phase-contrast and fluorescence micrographs demonstrate the representative phenotypes of GFP- or GFP-TSC2–infected cells. TSC2/ cells, infected
with GFP-TSC2 or control GFP replication-deficient adenovirus constructs, were first serum-deprived, and then subjected to live image analysis of wound
closure in the presence of 2% FBS. Short arrows indicate differences in membrane protrusion; long arrows indicate direction of cell movement. Bars, 120
m. Images were taken using a Leitz Inverted Microscope in both the phase-contrast and green fluorescence channels. Images are representative from
three independent experiments. (C) Statistical analysis of the rate of membrane protrusion in TSC2/ cells infected either with GFP or GFP-TSC2.
*, P  0.0001 for GFP-TSC2-infected cells versus GFP-infected cells by ANOVA (Bonferroni-Dunn test).
1172
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smooth muscle ELT3 cells, which were either untreated or
transduced with a replication-deficient adenovirus expressing
GFP-tagged wild-type TSC2 or control GFP. As shown in Fig.
1 A and Video 1 (available at http://www.jcb.org/cgi/content/
full/jcb.200405130/DC1), TSC2/ cells retained their motile
properties (Irani et al., 2002); however, their movement was
characterized by the formation of short lamellipodia at the
leading edge of migrating cells. Expression of GFP-tagged
TSC2 markedly changed the pattern of cell dynamics; during
wound closure, moving cells formed dynamic membrane protrusions, and the rate of membrane extension for GFP-TSC2–
infected cells was 1.00  0.25 m min1 compared with
0.35  0.08 m min1 for GFP-infected cells (Fig. 1, B and
C; and Videos 2 and 3, available at http://www.jcb.org/cgi/
content/full/jcb.200405130/DC1). Expression of control GFP
in TSC2/ cells had little effect on the pattern of cell move-

ment (Fig. 1 B and Videos 4 and 5, available at http://
www.jcb.org/cgi/content/full/jcb.200405130/DC1). These data
demonstrate that reexpression of TSC2 markedly changes
TSC2/ cell morphology during cell motility and suggest
that TSC2 might be important for the formation of membrane
protrusions during directional movement.
TSC2 and TSC2-HBD regulate stress
fiber disassembly

Because cell motility is regulated by actin remodeling, we examined actin rearrangements in TSC2/ cells. F-actin staining revealed abundant stress fiber formation (Fig. 2 A, top).
Surprisingly, PDGF, which promotes stress fiber disassembly
and lamellipodia formation in most cell types (Zigmond, 1996)
and promoted stress fiber disassembly in 3T3 cells (Fig. 2 A,
bottom), had little effect on actin rearrangements and lamelli-

Figure 2. PDGF has little effect on stress fiber disassembly in TSC2/ cells. (A) Rhodamine phalloidin
staining of F-actin of serum-deprived TSC2/ and
3T3 cells, which were either stimulated with 10 ng/ml
of PDGF () or diluent () for 10 min. PDGFR activation in TSC2/ cells: serum-deprived cells, transfected with either GFP or GFP-TSC2, were stimulated
with PDGF. Equalized in protein content whole cell
lysates were subjected to immunoprecipitation with
either anti-PDGFR (B) or PDGFR (C) antibodies;
and then immunoblot analysis was performed with
either anti-PDGFR, PDGFR, or anti-phosphotyrosine
(PY) antibodies.
TSC1, TSC2, AND RAC1 • GONCHAROVA ET AL.
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Figure 3. Schematic representation and expression of GFP-tagged TSC2 constructs in the TSC2/ cells. (A) TSC2 includes leucine zipper (LZ), two
coiled-coiled (CC), two transcription-activating domains (TAD), GAP homology (GAP), and calmodulin (CaM)-binding domain. (B) To identify expression of TSC2 mutants, cells were transfected with pEGFP vectors expressing GFP-tagged TSC2, N-TSC2, C-TSC2, TSC2-HBD, TSC2-HBD, or control
GFP. After 24 h of transient transfection, cells were lysed, and whole cell lysates were subjected to 8% SDS-PAGE followed by immunoblot analysis
with anti-GFP antiserum. TSC2-positive rat TRKE cells, used as a positive control, were lysed and subjected to 8% SDS-PAGE followed by immunoblot
analysis with anti-TSC2 antibody.

podia formation in TSC2/ cells (Fig. 2 A, top). This finding
was more surprising because we previously demonstrated that
PDGF stimulates migration of TSC2/ ELT3 cells (smooth
muscle cells derived from Eker rat uterine leiomyomas; Irani et
al., 2002). Because Zhang et al. (2003) demonstrated that
PDGF receptor (PDGFR)  and PDGFR levels were reduced
in TSC2/TP53/ murine embryonic fibroblasts, we examined their expression in TSC2/ rat ELT3 cells. Immunoblot analysis revealed that PDGFR and PDGFR are expressed in these cells, and TSC2 expression had little effect on
both receptor levels (Fig. 2, B and C). Stimulation of cells with
PDGF-BB induced activation of PDGFR, but has little effect
on PDGFR (Fig. 2, B and C, respectively). These data suggest
that PDGF-induced signaling is not defective in rat TSC2/
cells at the receptor levels.
To examine whether TSC2 is required for actin remodeling, and to identify which domain of TSC2 is important for
stress fiber disassembly, we tested a panel of GFP-tagged deletion constructs of TSC2 (Fig. 3). The reexpression of fulllength TSC2 in TSC2/ cells markedly promoted stress fiber
disassembly and the formation of cortical actin compared with
cells transfected with control GFP (Fig. 4 A). Interestingly, the
expression of TSC2-HBD in TSC2/ cells containing the
Rheb GAP domain (Fig. 4 A) or the expression of C-TSC2 (not
depicted) had little effect on stress fiber disassembly. In contrast, expression of N-TSC2 (not depicted) or TSC2-HBD was
sufficient to induce stress fiber disassembly (Fig. 4 A).
Stress fiber assembly is regulated by activation of Rho
GTPase, which could be activated by TSC1 through its Rhoactivating domain (Lamb et al., 2000). Because TSC2 binds
1174
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TSC1 (Nellist et al., 1999, 2001; Hodges et al., 2001) by the
domain that overlaps the Rho-activating domain of TSC1 and
potentially inhibits TSC1-dependent Rho activation, we investigated whether or not stress fiber disassembly involves TSC1.
As seen in Fig. 4 A, microinjection of siRNA in TSC2/
cells directed against TSC1 promoted stress fiber disassembly
similar to the effects of the expression of TSC2 or TSC2-HBD.
Because TSC2-HBD had no effect on stress fiber disassembly, but TSC2-HBD and siRNA TSC1 were sufficient to produce this effect in TSC2/ cells, these data suggest that
TSC2-dependent actin remodeling involves TSC1.
Quantitative analysis of F-actin staining revealed that
94.6  1.7% of GFP-transfected cells showed stress fibers;
in contrast, TSC2, TSC2-HBD, or siRNA TSC1 promoted
marked stress fiber disassembly by 42.3  1.9%, 52.7  1.5%,
and 31.7  2.6%, respectively (Fig. 4 B). Because TSC2 is a
susceptibility factor for LAM disease, we tested whether TSC2
or TSC2-HBD will affect actin remodeling in primary cultures
of cells derived from the LAM tumors (Goncharova et al.,
2002). As seen in Fig. 4 C, TSC2 and TSC2-HBD expression
also promoted stress fiber disassembly in human LAM-derived
(LAMD) cells, suggesting that TSC2 might be important for
abnormal metastatic cell growth associated with TSC2 deficiency in LAM (Henske, 2003).
TSC2 or TSC2-HBD promotes focal
adhesion remodeling

Because actin rearrangements are accompanied by focal adhesion remodeling, we examined whether or not TSC2-induced
stress fiber disassembly correlates with changes in focal adhe-

Figure 4. TSC2, TSC2-HBD, and siRNA TSC1 promote stress fiber disassembly. (A, left) F-actin staining (red) of TSC2/ cells transfected with GFP-TSC2
or the indicated GFP-tagged TSC2 constructs identified by immunostaining with anti-GFP antibody (green) or microinjected with siRNA TSC1 and GST to
identify injected cells (green). (right) Schematic representation of TSC2 constructs. Bar, 20 m. (B) Quantitative analysis of F-actin staining. Data represent
the percentage of cells with stress fibers per total number of cells transfected with pEGFP, pEGFP-TSC2, pEGFP-TSC2-HBD, or pEGFP-TSC2-HBD taken as
100%. A total of 205 of GFP-TSC2–transfected, 360 of GFP-TSC2-HBD–transfected, 302 of GFP-TSC2-HBD–transfected, 331 of GFP-transfected, and 644
siRNA TSC1-microinjected cells were analyzed from three independent experiments. Data represent the mean  SE. *, P  0.0001 for GFP-TSC2–, GFPTSC2-HBD–transfected cells, or siRNA TSC1  GST-microinjected cells versus GFP-transfected cells by ANOVA (Bonferroni-Dunn test). (C) Statistical analysis
of F-actin staining of LAMD cells transfected with GFP, GFP-TSC2, GFP-TSC2-HBD, and GFP-TSC2-HBD. Data represent the mean  SE from two independent
experiments. *, P  0.001 for GFP-TSC2– and GFP-TSC2-HBD–transfected cells versus GFP-transfected cells by ANOVA (Bonferroni-Dunn test).

sion formation. Immunohistochemical analysis with anti-vinculin antibody showed that in TSC2/ cells focal adhesions
were localized throughout the cell as well as at the cell periphery (Fig. 5 A, top; and Video 6, available at http://www.
jcb.org/cgi/content/full/jcb.200405130/DC1). Expression of
TSC2 promoted marked changes in the shape and size of the
focal adhesions: most focal adhesions in the center of the cells
were disassembled, and the quantity of focal adhesions per
cell was attenuated by 30.3  5.9% compared with control. At
the same time, the size of focal adhesions at the cell periphery
was also markedly decreased (Fig. 5 A, middle; and Video 7,
available at http://www.jcb.org/cgi/content/full/jcb.200405130/
DC1). Importantly, TSC2-HBD, which is involved in TSC1–

TSC2 complex formation, also promoted focal adhesion disassembly in the center of the cells (Fig. 5 A, bottom; and Video
8, available at http://www.jcb.org/cgi/content/full/jcb.200405130/
DC1). TSC1 regulates cell adhesion, and its inactivation results in the loss of focal adhesion (Lamb et al., 2000). To determine if focal adhesion remodeling in TSC2/ cells requires TSC1, we microinjected siRNA TSC1 and found that
down-regulation of TSC1 promoted focal adhesion disassembly in TSC2/ cells (Fig. 5 B). These results demonstrate
that expression of TSC2-HBD and the down-regulation of
TSC1 with siRNA TSC1 are sufficient for focal adhesion disassembly, which suggest that TSC2 involves TSC1 in regulating focal adhesion remodeling.
TSC1, TSC2, AND RAC1 • GONCHAROVA ET AL.
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Figure 5. TSC2, TSC2-HBD, and siRNA TSC1 modulate focal adhesion formation. (A) Cells were transfected with control pEGFP (top), pEGFP-TSC2 (middle),
or pEGFP-TSC2-HBD (bottom) plasmid, and then immunostained with anti-GFP (green) and anti-vinculin (red) antibodies to detect focal adhesions. Images are
representative of three separate experiments. (B) Cells were transfected with control GST, GST-tagged V12Rac1, or siRNA TSC1 comicroinjected with GST to
identify microinjected cells, followed by immunostaining with anti-GST (green) and anti-vinculin (red) antibodies. Representative images from 138 microinjected cells. Changes in the shape and size of the focal adhesion are represented in enlarged insets (1–3). Bars: (A and B) 30 m; (insets) 10 m.

Because the cortical actin staining observed in TSC2-transfected cells was reminiscent of the effects of Rac1 (Etienne-Manneville and Hall, 2002) and because small GTPase Rac1 induces
the formation of membrane ruffles and lamellipodia, which ultimately results in focal adhesion remodeling, we examined the effect of the constitutively active form of Rac1 (V12Rac1) on focal
adhesion formation in TSC2/ cells. Vinculin immunostaining
showed that V12Rac1 expression induced marked changes in focal adhesion formation similar to effects of TSC2 (Fig. 5 B), suggesting a potential link between TSC2 and Rac1 signaling.

Figure 6. TSC2, TSC2-HBD, and siRNA TSC1 activate Rac1. (A) TSC2/
cells were stimulated with 10 ng/ml of PDGF or diluent for 10 min or transfected with plasmids expressing GFP-tagged TSC2 or TSC2-HBD, or GFP
as a control, or microinjected with siRNA TSC1 or control siRNA, and then
subjected to the Rac1 activity assay. (top) Immunoblot analysis with antiRac1 antibody to detect Rac1 in pull-down assay with PAK-1 PBD agarose
(top images) and in whole cell lysates (bottom images). Images are representative of three separate experiments. (bottom) Quantitative analysis of
Rac1 activity assays using Gel-Pro Analyzer Software. Rac1 activity in cells
transfected with control pEGFP plasmid was taken as a onefold. *, P 
0.001 for GFP-TSC2 versus GFP; **, P  0.001 for GFP-TSC2-HBD versus
GFP; ***, P  0.001 for siRNA TSC1 versus control siRNA. Data represent the mean  SE from three independent experiments. (B) LAMD cells
were transfected with GFP-TSC2, GFP-TSC2-HBD, or GFP as a control, and
then Rac1 activity assay was performed. (top) Immunoblot analysis with
anti-Rac1 antibody to detect Rac1 in pull-down assay with PAK-1 PBD
agarose (top images) and in whole cell lysates (bottom images). Images
are representative of two separate experiments. (bottom) Quantitative analysis of Rac1 activity. Data represent the mean  SE from two independent
experiments. *, P  0.001 for GFP-TSC2 versus GFP; **, P  0.001 for
GFP-TSC2-HBD versus GFP by ANOVA (Bonferroni-Dunn test). White lines
indicate that intervening lanes have been spliced out.
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Figure 7. TSC2 and TSC2-HBD inhibit Rho activity in
TSC2/ cells. (A) TSC2/ cells were transfected
with pEBG-V12Rho or GFP-TSC2; GFP-TSC2 was
cotransfected with pEBG-V12Rho plasmids; or pEGFPTSC2-HBD was cotransfected with pEBG-V12Rho
plasmid; and then cells were stained with anti-GFP to
detect GFP, GFP-TSC2, or GFP-TSC2-HBD (green),
anti-GST to detect GST, or GST-V12Rho (blue) and
rhodamine phalloidin to detect F-actin (red). Images
are representative of three independent experiments.
Bar, 20 m. (B) Cells were transfected with pEGFPTSC2, pEGFP-TSC2-HBD, and control pEGFP plasmids expressing GFP-tagged TSC2, GFP-TSC2-HBD,
and control GFP, respectively, and then Rho activity
assay was performed. Immunoblot analysis of RhoGTP pull-down with Rhotekin-RBD agarose (top) and
whole cell lysates (bottom) was performed with antiRho antibodies. White lines indicate that intervening
lanes have been spliced out. Quantitative analysis of
three independent experiments was performed using
Gel-Pro Analyzer Software. *, P  0.001 for GFPTSC2 versus GFP; **, P  0.001 for GFP-TSC2-HBD
versus GFP by ANOVA (Bonferroni-Dunn test).

Activation of Rac1 by TSC2

To clarify the function of Rac1 in TSC2-induced stress fiber
disassembly and focal adhesion remodeling, we next examined
Rac1 activation in TSC2/ cells. Stimulation of TSC2/
cells with PDGF had little effect on the basal Rac1 activity
(Fig. 6 A), whereas PDGF-stimulated Rac1 activity in 3T3
cells (not depicted), which were used as a model cell line. By
expressing TSC2 in TSC2/ cells, we found that TSC2 alone
was sufficient to markedly increase Rac1 activity compared
with cells transfected with control GFP (Fig. 6 A). Similarly,
Rac1 activity was increased in LAMD cells transfected with
TSC2, indicating that TSC2 may elicit activation of Rac1
(Fig. 6 B). Importantly, down-regulation of TSC1 with TSC1

siRNA or expression of TSC2-HBD was also sufficient for
stimulating Rac1 activity (Fig. 6 A), suggesting that TCS2 interaction with TSC1 may be involved in the regulation of Rac1
activity. We conclude that TSC2 acts upstream of Rac1 in pathways regulating actin and focal adhesion remodeling.
TSC2 and TSC2-HBD inhibit Rho activity

The small GTPase RhoA is necessary for stress fiber and focal
adhesion formation (Etienne-Manneville and Hall, 2002) and
TSC1 activates Rho (Lamb et al., 2000). To determine whether
or not TSC2-induced stress fiber disassembly was by impaired signaling downstream of Rho, we cotransfected TSC2
or TSC2-HBD with constitutively active Rho, V14Rho. As seen
TSC1, TSC2, AND RAC1 • GONCHAROVA ET AL.
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in Fig. 7 A (panels III and IV, respectively), in cells cotransfected with V14Rho, stress fibers were maintained compared
with cells expressing TSC2 alone (Fig. 7 A, panel II). These
data suggest that stress fiber disassembly induced by TSC2 and
TSC2-HBD is not due to failure in pathways downstream of
Rho that regulate assembly and maintenance of stress fibers.
To investigate whether or not TSC2 may modulate Rho
activity, we examined if TSC2 expression affected endogenous
Rho activity in TSC2/ cells. As seen in Fig. 7 B, TSC2
modestly but reproducibly attenuated Rho activity by 64 
13% compared with GFP-transfected cells. TSC2-HBD alone
was also sufficient for the attenuation of Rho activity by 40 
9% compared with control GFP (Fig. 7 B). Together, these results indicate that TSC2-induced actin rearrangements involve
activation of Rac1 and inhibition of Rho.
Rac1 acts upstream of Rho in TSC2dependent actin remodeling

Rho and Rac1 both regulate stress fiber formation and focal adhesion remodeling in a reciprocal manner, as such activation of
Rac1 results in the inhibition of Rho and vice versa (Horwitz
and Parsons, 1999). To clarify the hierarchy of Rho inhibition
and Rac1 activation in TSC2-dependent stress fiber disassembly, we analyzed whether or not the activated form of Rac1,
V12Rac1, could promote actin rearrangements in TSC2/
cells; and then we performed cotransfection experiments of
dominant-negative GST-tagged Rac1 (N17Rac1) with TSC2.
Expression of V12Rac1 promoted stress fiber disassembly in
the cell center and formation of cortical actin at the cell periphery similar to the effect of TSC2 (Fig. 8 A, top and middle, respectively). In contrast, in cells coexpressing N17Rac1 and
TSC2, stress fibers were maintained (Fig. 8 A, bottom), suggesting that TSC2-induced stress fiber disassembly requires
Rac1 activation. Furthermore, when N17Rac1 was comicroinjected with siRNA TSC1, stress fibers also remained (Fig. 8 B,
bottom), indicating that TSC1-dependent stress fiber formation
requires the negative regulation of Rac1 activity. Quantitative
analysis of these experiments is presented in Fig. 8 C. Because
stress fibers are maintained by active Rho, and inactive Rac1
coexpressed with TSC2 or siRNA TSC1 does not promote
stress fiber disassembly, this data indicates that TSC2 requires
activation of Rac1, followed by inhibition of Rho, in regulating
actin remodeling.
Figure 8. Dominant-negative Rac1 abrogates TSC2- and siRNA TSC1induced stress fiber disassembly. (A) Serum-deprived cells were transfected with pEBG-V12Rac1 expressing activated Rac1 or the cells were
cotransfected with pEGFP-TSC2 and pEBG-N17Rac1 plasmids, expressing
GFP-TSC2 and GST-N17Rac1, respectively, and were stained with antiGFP to detect GFP-TSC2 (green), anti-GST to detect GST, GST-V12Rac1,
GST-N17Rac1 (blue), and phalloidin rhodamine to detect F-actin (red). Images are representative of three independent experiments. Bar, 20 m. (B)
Cells, microinjected with GST-N17Rac1, comicroinjected with siRNA
TSC1 and GST to identify microinjected cells, or comicroinjected with
siRNA TSC1 and N17Rac1, were stained with anti-GST antibody to detect
GST and GST-N1Rac1 (green) and phalloidin rhodamine to detect F-actin
(red). Images are representative of three independent experiments. (C)
Quantitative analysis of F-actin staining. Data represent the percentage of
cells with stress fibers per total number of cells transfected with plasmids
expressing GST, GST-V12Rac1, GST-N17Rac1, GFP-TSC2, or coexpressed GFP-TSC2 and GST-N17Rac1, siRNA TSC1 and GST-N17Rac1,
1178
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TSC2-HBD is not required for the
negative regulation of ribosomal protein
S6 activation

To address the relationship between the role that TSC2 plays in
regulating actin dynamics and its function as a negative regulator
of protein translation through mTOR, we examined the effect of

or siRNA TSC1 and control GST taken as 100%. Data represent the
mean  SE from three independent experiments. *, P  0.001 for GSTV12Rac1 versus GST, siRNA TSC1  GST versus siRNA TSC1  GSTN17Rac1, and GFP-TSC2 versus GFP-TSC2  GST-N17Rac1 by ANOVA
(Bonferroni-Dunn test).

Figure 9. Expression of TSC2, but not TSC2-HBD, inhibits ribosomal protein S6 phosphorylation and DNA synthesis in TSC2/ cells. TSC2/ cells
were transfected with plasmids expressing GFP-tagged TSC2, TSC2-HBD, or TSC2-HBD, or comicroinjected with pEGFP-TSC2-HBD and pEGFP-TSC2HBD plasmids, serum-deprived for 24 h, and immunostained with anti–phospho-S6 (red) antibody and anti-GFP antiserum (green); or BrdU incorporation
analysis was performed. (A) Representative images of three separate experiments were taken. Arrows indicate transfected cells. (B) Quantitative analysis
of P-S6 immunostaining. Data represent the percentage of P-S6–positive transfected cells per total number of transfected cells. *, P  0.001 for GFP-TSC2
versus GFP; **, P  0.001 for GFP-TSC2-HBD versus GFP; ***, P  0.001 for GFP-TSC2-HBD  GFP-TSC2-HBD versus GFP. (C) BrdU incorporation
analysis of transfected cells. Mitotic index represents the percentage of BrdU-positive transfected cells compared with the total number of transfected cells.
Data are mean  SE of three separate experiments. *, P  0.001 for GFP-TSC2 versus GFP; **, P  0.001 for GFP-TSC2-HBD versus GFP; ***, P 
0.001 for GFP-TSC2-HBD  GFP-TSC2-HBD versus GFP.

rapamycin, a specific mTOR inhibitor, on the actin cytoskeleton
in the TSC2/ cells at a dose that completely abrogates S6K
activity. We found that rapamycin had little effect on actin dynamics (unpublished data), which serves as evidence that the
regulation of cell dynamics is a novel function of TSC2, which is
independent from its function in protein translational regulation.
Because TSC2 negatively regulates the activity of ribosomal protein S6 by inhibition of its phosphorylation (Goncharova et al., 2002), we investigated whether TSC2-HBD or
TSC2-HBD affects ribosomal protein S6 hyperphosphorylation in TSC2/ cells. Consistent with previously published
results (Goncharova et al., 2002), full-length TSC2 inhibited
S6 phosphorylation by 56.2  3.9% compared with GFP-transfected cells (Fig. 9, A and B). TSC2-HBD also significantly,
however to a lesser extent than full-length TSC2, inhibited S6
phosphorylation by 22.7  2.8%. Importantly, comicroinjection of TSC2-HBD and TSC2-HBD inhibited phospho-S6 by
47.4  3.3%, which was comparable to the inhibitory effect of
full-length TSC2 (Fig. 9 B). In contrast, expression of TSC2HBD had little effect on S6 phosphorylation, suggesting that
this domain of TSC2 is not required for the regulation of ribosomal protein S6 activation (Fig. 9, A and B).
In parallel, we examined the effect of TSC2 mutants on
DNA synthesis. As we previously demonstrated (Goncharova
et al., 2002), TSC2, but not TSC2-HBD, significantly inhibited
TSC2/ cell proliferation by 49.4  4.7%. Importantly,
TSC2-HBD alone was sufficient for inhibition of DNA synthesis, however, to a much lesser extent than full-length TSC2.
By coexpressing TSC2-HBD and TSC2-HBD we found that
DNA synthesis was inhibited by 43.2  1.4%, which was comparable to inhibition by full-length TSC2 (Fig. 9 C). Collectively, these data demonstrate that TSC2-HBD is not required
for S6 phosphorylation and regulation of DNA synthesis.

Discussion
TSC1 has been identified as an activator of Rho and a regulator
of cell adhesion (Lamb et al., 2000). The Rho-activating domain of TSC1 overlaps with the region that binds TSC2 (Nellist et al., 1999, 2001; Hodges et al., 2001), indicating that
TSC2 may modulate TSC1-dependent activation of Rho. Our
work identifies a novel function of TSC2 as a modulator of
the actin cytoskeleton and focal adhesion remodeling. In our
model, TSC1 inhibits Rac1, and TSC2 blocks this activity of
TSC1 that is a prerequisite to the activation of Rac1 and the
subsequent inhibition of Rho; this, in turn, promotes stress fiber disassembly and focal adhesion remodeling (Fig. 10). Loss
of function of either TSC1 or TSC2 due to inactivating mutations potentially promotes deregulation of the TSC1–TSC2
complex formation followed by deregulation of Rac1 and Rho
activities, which, consequently, induces abnormal cell motility
associated with the pathobiology of LAM and TSC.
Actin dynamics is a major cellular process regulating cell
morphogenesis, movement, and behavior. In the normal cellular
context, directional cell movement requires the formation of
membrane protrusions and new focal adhesions, and stabilization of existing adhesions, which are regulated by Rho GTPases. Activity of these GTPases is modulated by a plethora of
signaling molecules among which TSC2 appears as an important physiological modulator. Activation of Rac1 by reexpression of TSC2 in TSC2/ cells resulted in the reorganization of the actin cytoskeleton and focal adhesion remodeling.
Through attenuation of Rho activity, TSC2 facilitates stress fiber disassembly and focal adhesion remodeling, thus consequently promoting dynamic membrane protrusions. Our work
indicates that TSC2 functions as a modulator of Rac1 and Rho
activation and actin remodeling, which involves TSC1. TSC1, a
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Figure 10. Schematic representation of the TSC2-dependent modulation of
actin cytoskeleton and focal adhesion. TSC1 inhibits Rac1, and TSC2 blocks
this activity of TSC1. TSC2 through its specific TSC1-binding domain forms
a complex with TSC1, which is a prerequisite for Rac1 activation and Rho
inhibition. This, in turn, promotes stress fiber disassembly and focal adhesion remodeling. Dysregulation of TSC2 function due to inactivating mutations promotes deregulation of the TSC1–TSC2 complex formation, followed
by deregulating Rac1 and Rho activation, which, in turn, results in abnormal
cell motility and adhesion associated with LAM and TSC pathobiology.

binding partner of TSC2 (Nellist et al., 1999; Henske, 2003;
Krymskaya and Shipley, 2003), regulates the activity of Rho
and associates with the cortical proteins ERM, which serve as
molecular bridges between the plasma membrane and the cortical actin (Lamb et al., 2000). The fact that TSC2 binds TSC1
through TSC2-HBD (van Slegtenhorst et al., 1998; Benvenuto
et al., 2000; Hodges et al., 2001), which overlaps with the Rhoactivating domain of TSC1 (Lamb et al., 2000), suggests the
critical importance of the TSC2–TSC1 interaction for TSC1dependent Rho activation and cell adhesion. Our data show that
Rho can be inhibited by the reexpression of TSC2, which contradicts a previous paper by Astrinidis et al. (2002) in which the
stable expression of TSC2 in the same TSC2/ cells results
in Rho activation. The possible reason for the discrepancy between our data and the previous paper lies within the potential
differences in the mode of cell motility that differ in their requirement for Rho activation (Martin, 2003; Sahai and Marshall, 2003) due to differences in experimental approaches. Using transient TSC2 expression by mammalian expression vector
or adenoviral infection in TSC2/ cells, we show that TSC2
promotes “classical” lamellipodial or mesenchymal motility
driven by activated Rac1 and the down-regulation of Rho activation. In contrast to this classical type of motility, some tumor
cell lines require Rho activation to promote a rounded blebassociated mode of motility (Sahai and Marshall, 2003). Astrinidis et al. (2002) use ELT3 and MDCK cell clones with stable
overexpression of TSC2. We can’t rule out that cell lines stably
overexpressing TSC2 had changed their phenotype with concomitant alterations in the mode of motility that requires Rho
activation as it is demonstrated by Astrinidis et al. (2002). Our
data also show that Rac1 acts upstream of Rho in TSC1–TSC2–
dependent actin remodeling. How TSC1–TSC2 activates Rac1
1180

JCB • VOLUME 167 • NUMBER 6 • 2004

and inhibits Rho remains to be elucidated. One possibility is
that TSC1–TSC2 may modulate the activity of kinases regulating Rac1/RhoGDI association (DerMardirossian et al., 2004).
Additionally, differential cellular localization of TSC2 and its
mutants (unpublished data) suggests that TSC2 functions in
regulating Rac1 activity or in the complex formation with TSC1
may depend on the subcellular localization of TSC2, TSC1, and
Rac1. Another avenue to explore in elucidating the relationship
between TSC1–TSC2 and Rac1 is to determine the modulation
of growth factor–stimulated Rac1 activity by TSC1–TSC2.
TSC2 regulates cell growth and proliferation through the
mTOR/S6K signaling pathway, which is sensitive to rapamycin, thus inhibiting mTOR. In TSC2/ cells, we determined
that actin remodeling was insensitive to rapamycin, suggesting
that the rapamycin-sensitive mTOR pathway does not contribute to biochemical events that occur as a part of the regulatory
mechanisms of cell dynamics. Further support for this observation was provided by the phosphorylation level of ribosomal
protein S6, which was unaffected by expression of TSC2HBD, a domain of TSC2, which was necessary and sufficient
to regulate Rac1/Rho activities and actin remodeling. Importantly, TSC2-HBD, which contains the GAP homology domain, is not involved in TSC2-dependent actin rearrangement
but is sufficient for the modulation of mTOR/S6K activity,
which suggests that different domains of TSC2 are involved in
the regulation of cell dynamics and protein translation/cell
growth through activation of two independent signaling pathways. Because TSC2 is an upstream regulator of mTOR, and in
yeast TOR controls the actin cytoskeleton (Schmelzle and Hall,
2000), further studies are needed to address the question of
whether or not the rapamycin-insensitive component of mTOR
is involved in TSC2-dependent actin dynamics.
Our current findings provide evidence that TSC2 plays an
important role in regulating cell dynamics. Notably, the function
of TSC2-HBD, which is essential for the TSC2-dependent regulation of the actin cytoskeleton and focal adhesion, is not required
for the regulation of S6 phosphorylation and cell growth, indicating that TSC2 may influence both cell dynamics and protein
translation. It is important to note that activation of Rac1 is required for neurite outgrowth (Kozma et al., 1997; Yamaguchi et
al., 2001). In contrast, Rho activation promotes neurite retraction
and an inhibition of neurite outgrowth (Katoh et al., 1998;
Yamaguchi et al., 2001). Because the loss of TSC1 or TSC2 functions promotes aberrant neuronal motility during brain development (Crino and Henske, 1999; Vinters et al., 1999; Gutmann et
al., 2000; Sparagana and Roach, 2000), TSC1 and TSC2 loss of
functions may deregulate Rac and Rho activities, which may then
contribute to TSC pathology. Because TSC and LAM disease severity is predominantly associated with the loss of TSC2 function,
the perturbed balance between TSC2 and TSC1 interaction could
be a key event in the pathobiology of TSC and LAM.

Materials and methods
Cell culture
LAMD and TSC2/ ELT3 cells were derived from the Eker rat uterine
leiomyoma (Howe et al., 1995) and maintained as previously described
(Goncharova et al., 2002). TSC2/ ELT3 cells were a gift from C.L.

Walker (National Institute of Environmental Health Sciences Center for Research on Environmental Disease, Smithville, TX). 3T3 fibroblasts were
purchased from American Type Culture Collection (CCL-92) and maintained in DME supplemented with 10% FBS. All experiments were performed on serum-deprived cells before experiments for 24 h.
Plasmid and adenovirus construction
The pEGFP-TSC2, encoding GFP-tagged TSC2; pEGFP-N-TSC2, encoding
1–1113 amino acids of TSC2; and pEGFP-C-TSC2, encoding 1114–
1784 amino acids of TSC2 mammalian expression constructs were created as previously described (Finlay et al., 2004). The pEGFP-TSC2-HBD
or pEGFP-TSC2-HBD plasmids, expressing 1–460 amino acids or 461–
1784 amino acids of TSC2, respectively, were produced by digesting the
pEGFP-TSC2 plasmid, expressing wild-type human TSC2, with SalI and
FspI or FspI and XbaI endonucleases, respectively. These fragments were
ligated with pEGFP-C3 vector digested with SmaI and SalI or SmaI and
XbaI, respectively. Successful insertion of TSC2-HBD or TSC2-HBD into
pEGFP plasmid was confirmed by analytical digest and sequence analysis
with pEGFP-C Sequencing Primer (BD Biosciences). Recombinant adenovirus expressing GFP and TSC2 cDNA constructs were created using the
AdEasy vector system as described previously (Finlay et al., 2004). The
expression of GFP-tagged TSC2 mammalian expression constructs and adenoviruses was confirmed by transient transfection or adenovirus infection
of TSC2/ cells with these vectors and immunoblot analysis of whole
cell lysates with anti-GFP antibody (Fig. 3).
Transient transfection and replication-deficient adenovirus infection
Transient transfection was performed using the Effectene transfection reagent (QIAGEN) according to the manufacturer’s protocol. Infection with
replication-deficient adenovirus was performed as described previously
(Lanuti et al., 1999). Transfection and virus infection were used in parallel
and yielded similar results regarding the regulation of cell cytoskeleton,
motility, and the modulation of Rac1 and Rho GTPases activities. pEBGV14Rho, pEBG-N17Rac1, and pEBG-V12Rac1 expression vectors were a
gift from M.M. Chou (University of Pennsylvania, Philadelphia, PA).
Wound assay and live imaging of wound closure
Cells, plated on chamberslides, were wounded by scraping a 10-l pipette tip through the cell monolayer, and then gently washed with PBS, incubated with fresh media supplemented with 2% FBS for 2 h, followed by
supravital analysis. Supravital analysis was performed in the micro-incubator (model CSMI; Harvard Apparatus) with constant 37 C temperature on
an inverted microscope (model TE300; Nikon) equipped with a digital
video camera (model Evolution QEi; Media Cybernetics) under 100 magnification for 8.3 h. Images were taken every 10 min in both the phasecontrast and fluorescence channels and were analyzed using Image-Pro
Plus 5.0.0.39 software (Media Cybernetics).
Immunocytochemistry
Cells were washed three times with PBS, fixed with 3.7% PFA for 15 min,
treated with 0.1% Triton X-100 for 30 min at RT, and blocked with 0.5%
TSA Fluorescein System blocking reagent (NEN Life Science Products)
in TBS. After incubation with rhodamine phalloidin (Molecular Probes) or
primary and then secondary antibodies conjugated with either Alexa
Fluor488, Alexa Fluor594, or Alexa Fluor633 (see online supplemental
materials) cells were mounted in Vectashield mounting medium (Vector
Laboratories). Immunostaining was analyzed using the scanning laser confocal microscopic system (model TCS SP2; Leica), a microscope (model
Eclipse TE2000-E; Nikon) equipped with a digital video camera (model
Evolution QEi; Media Cybernetics), or a microscope (model Eclipse E400;
Nikon) equipped with a digital camera (model Coolpix 995; Nikon) under 1,000 magnification. Three-dimensional analysis was performed using Z-series images taken with z interval 0.1 m, which were then threedimensionally deconvoluted using AutoDebur  AutoVisualize Software
9.3 (AutoQuant Imaging, Inc.).
Immunoblot analysis
Serum-deprived TSC2/ cells were stimulated with 10 ng/ml of PDGFBB (Calbiochem) for 10 min followed by immunoblot analysis with antiPDGFR (Santa Cruz Biotechnology, Inc.), anti-PDGFR, and antiphosphotyrosine antibodies (Upstate Cell Signaling Solutions) as previously
described (Goncharova et al., 2002).
Rac and Rho activity assays
Cells were transfected with pEGFP-TSC2, pEGFP-TSC2-HBD, pEGFPTSC2-HBD, control pEGFP plasmid, siRNA TSC1, or siGLO RISC-Free

siRNA (Dharmacon Research, Inc.) as a control and growth arrested,
and then Rho or Rac activities were measured using Rac or Rho Activation Assay Kits (Upstate Cell Signaling Solutions) according to the manufacturer’s protocol. Rho and Rac1 were detected using anti-Rho (A, B, or
C) or anti-Rac1 antibodies, respectively (Upstate Cell Signaling Solutions). siRNA TSC1 sequences were a gift from R. Lamb (Institute for Cancer Research, London, UK); anti-TSC1 antibody was a gift from M. Nellist
(Erasmus University, Rotterdam, Netherlands).
Microinjection
Microinjection was performed using Eppendorf Microinjection System as
described previously (Goncharova et al., 2002). 18 h after injection, cells
were subjected to immunocytochemical or BrdU incorporation assays.
BrdUrd incorporation
Cells, transfected with plasmids expressed GFP-conjugated TSC2, TSC2HBD, TSC2-HBD, or GFP as a control, or coinjected with plasmids expressed TSC2-HBD and TSC2-HBD, were maintained for 24 h in serumfree medium, and BrdU incorporation was assessed (Goncharova et al.,
2002). The mitotic index was defined as the percentage of BrdU-positive
transfected/injected cells per field/total number of transfected/injected
cells per field.
Statistical analysis
Statistical analysis of F-actin staining or immunostaining was performed by
using microscope (model Eclipse E400; Nikon) images taken at 200 magnification followed by quantitative analysis using Gel-Pro Analyzer Software. Data points from individual assays represent the mean values 
standard error (SE). Statistically significant differences among groups were
assessed with the analysis of variance (ANOVA; Bonferroni-Dunn test),
with values of P  0.05 sufficient to reject the null hypothesis for all analyses. All experiments were designed with matched control conditions within
each experiment to enable statistical comparison as paired samples.
Online supplemental material
Down-regulation of TSC1 level by siRNA TSC1 and primary and secondary antibodies used for immunocytochemical analysis are listed in supplemental materials. The corresponding movie files of live cells are organized
as follows: Video 1 for Fig. 1 A and Videos 2–5 for Fig. 1 B. Movie files
demonstrating three-dimensional projection of cells immunostained with
anti-vinculin antibody are organized as follows: Videos 6–8 for Fig. 5.
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200405130/DC1.
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